Table 1.
Crude Prevalence of Abnormal Serum Lipid Valuesa in 30- to 70-Year-old Tibetans by Gender; Totals Adjusted to the WHO World Standard Population
Serum lipids (n = 371) | Male (n = 139) n (%) | Female (n = 232) n (%) | Total (n = 371) n (%) | Total adjusted (n = 371) % (95% CI) |
---|---|---|---|---|
Total cholesterol (mmol/L) | ||||
Borderline high (5.17–6.19) | 31 (23.3) | 60 (26.2) | 91 (24.5) | 27.78 (18.6, 37) |
High (≥6.20) | 10 (7.5) | 14 (6.1) | 24 (6.5) | 5.6 (−3.6, 14.7) |
Hypercholesterolemia (total) | 41 (30.8) | 74 (32.3) | 115 (31.0) | 33.52 (24.8, 42.1) |
High density lipoprotein (mmol/L) | ||||
Low HDL-C (<1.03 in men | 21 (15.1) | 62 (26.7) | 83 (22.4) | 24.34 (15.1, 33.5) |
Low HDL-C (<1.28 in women) | ||||
Low density lipoprotein (mmol/L) | ||||
High LDL-C (4.13–4.90) | 9 (6.8) | 5 (2.2) | 14 (3.9) | 3.72 (−6.1,13.5) |
Very high LDL-C (≥4.91) | 2 (1.5) | 2 (0.9) | 4 (1.1) | 1.03 (−8.7, 10.7) |
Triglycerides (mmol/L) | ||||
Hypertriglyceridemia (≥1.69) | 25 (18.8) | 19 (8.3) | 44 (12.2) | 11.97 (2.3, 21.5) |
National Cholesterol Education Programme (NCEP) adult treatment panel (ATP)-III criteria (Grundy et al., 2004).
CI, confidence interval.